Search Result "Secondary Cytoreduction"
Current Status of Primary Cytoreductive Surgery for the Treatment of Advanced Epithelial Ovarian Cancer
Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 1 Year: 2009 Page: 67-79
Author(s): Kaei Nasu, Harunobu Matsumoto, Noriyuki Takai, Hisashi Narahara
Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 25 Year: 2012 Page: 3793-3803
Author(s): Stefaan Mulier,Jean-Pierre Claes,Vincent Dierieck,Jean-Olivier Amiel,Jean-Philippe Pahaut,Luc Marcelis,Fabienne Bastin,Denis Vanderbeeken,Claude Finet,Sophie Cran,Thierry Velu
Current Treatment of Relapsed Ovarian Carcinoma
Journal: Current Cancer Therapy Reviews
Volume: 2 Issue: 3 Year: 2006 Page: 211-221
Author(s): Aristotle Bamias, Alexandros Rodolakis, Meletios A. Dimopoulos
Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy
Journal: Current Drug Discovery Technologies
Volume: 6 Issue: 1 Year: 2009 Page: 72-81
Author(s): Kurt Van der Speeten, Oswald Anthony Stuart, Paul H. Sugarbaker
How Targeted Therapy Influence Renal Surgery for Renal Cell Carcinoma
Journal: Current Drug Targets
Volume: 21 Issue: 15 Year: 2020 Page: 1550-1557
Author(s): Francesco Greco,Michele Marchioni,Francesco Esperto,Rocco Papalia,Luigi Schips,Roberto M. Scarpa
Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 5 Issue: 1 Year: 2006 Page: 61-77
Author(s): Luis Escribano, Cem Akin, Mariana Castells, Lawrence B. Schwartz
Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 30 Year: 2016 Page: 4717-4728
Author(s): Bradley J. Monk,Thomas J. Herzog,Krishnansu S. Tewari
Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance
Journal: Current Drug Targets
Volume: 21 Issue: 2 Year: 2020 Page: 167-178
Author(s): Ling Wang,Qi Wang,Yangchun Xu,Manhua Cui,Liying Han
Suppressing Glioblastoma Stem Cell Function by Aldehyde Dehydrogenase Inhibition with Chloramphenicol or Disulfiram as a New Treatment Adjunct: A Hypothesis
Journal: Current Stem Cell Research & Therapy
Volume: 4 Issue: 4 Year: 2009 Page: 314-317
Author(s): Richard E. Kast, Cristobal Belda-Iniesta
Targeting Angiogenesis in Ovarian Carcinoma
Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 3 Year: 2009 Page: 188-202
Author(s): Marta Mendiola, Jorge Barriuso, David Hardisson